Trials (Vall d'Hebron Barcelona Hospital Campus): Revision history

15 December 2025

• curprev 13:5413:54, 15 December 2025‎ Francine talk contribs‎ 322,056 bytes +207‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 321,849 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 16:5116:51, 4 December 2025‎ Larysse talk contribs‎ 320,148 bytes +47‎ No edit summary undo

2 December 2025

• curprev 14:0114:01, 2 December 2025‎ Lucas talk contribs‎ m 320,101 bytes +90‎ Update categories. undo

26 August 2024

• curprev 21:3221:32, 26 August 2024‎ Victor talk contribs‎ m 320,011 bytes 0‎ Victor moved page Trials (Vall d’Hebron Barcelona Hospital Campus) to Trials (Vall d'Hebron Barcelona Hospital Campus) undo
• curprev 21:3221:32, 26 August 2024‎ Victor talk contribs‎ 320,011 bytes −2‎ No edit summary undo

5 December 2023

• curprev 16:3316:33, 5 December 2023‎ Francine talk contribs‎ 320,013 bytes +320,013‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Vall d’Hebron Barcelona Hospital Campus page '''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''':..."